RNXT
RenovoRx Inc
NASDAQ: RNXT · HEALTHCARE · BIOTECHNOLOGY
$0.85
+2.27% today
Updated 2026-04-30
Market cap
$37.84M
P/E ratio
—
P/S ratio
33.70x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$1 – $1
Volume
0.4M
RenovoRx Inc (RNXT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+3.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+27.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-10.8%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-25.0%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $-0.08 | +2.7% | $1.01 | $0.98 | -3.0% |
| 2025-12-31 | $-0.08 | +0.0% | $0.87 | $0.84 | -4.5% |
| 2025-11-13 | $-0.08 | +0.0% | $1.00 | $0.75 | -25.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.08 | $-0.08 | +2.7% | — | — |
| 2025-12-31 | $-0.08 | $-0.08 | +0.0% | $238000.00 | +453.5% |
| 2025-09-30 | $-0.08 | $-0.08 | +0.0% | $266000.00 | — |
| 2025-06-30 | $-0.09 | $-0.08 | +11.1% | $422000.00 | — |
| 2025-03-31 | $-0.10 | $-0.11 | -10.0% | $197000.00 | — |
| 2024-12-31 | $-0.13 | $-0.12 | +4.0% | $43000.00 | — |
| 2024-09-30 | $-0.12 | $-0.10 | +14.3% | — | — |
| 2024-06-30 | $-0.10 | $-0.10 | +0.0% | — | — |
| 2024-03-31 | $-0.14 | $-0.07 | +50.0% | — | — |
| 2023-12-31 | $-0.30 | $-0.31 | -3.3% | — | — |
| 2023-09-30 | $-0.30 | $-0.13 | +56.7% | — | — |
Frequently asked questions
Has RenovoRx Inc beaten earnings estimates?
RenovoRx Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +3.4% over the last 4 quarters.
How does RNXT stock react to earnings?
RNXT stock has moved an average of -10.8% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.